» Articles » PMID: 7579537

Insulin Inhibits Its Own Secretion from Isolated, Perifused Human Pancreatic Islets

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 1995 Jun 1
PMID 7579537
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

It is still a controversial question whether insulin suppresses its own secretion. We prepared pure human islets from three pancreases by collagenase digestion and density gradient purification. Aliquots of 200 islet equivalents (IE, 150-microns sized-islets) were sequentially perifused at 37 degrees C with 3.3 mmol/l glucose (3.3G, 40 min), 16.7 mmol/l glucose (16.7G, 30 min) and again 3.3G (30 min) after 24 h, 37 degrees C culture in CMRL 1066 medium with or without the addition of either 200 or 400 microU/ml human insulin in the incubation medium (6 replicates each). Insulin secretion was assessed by C-peptide (Cp) measurement in the perifusate. Without added insulin (C) and with 200 (Ins200) or 400 (Ins400) microU/ml added insulin, basal Cp release was 0.12 +/- 0.03, 0.14 +/- 0.02 and 0.14 +/- 0.04 ng/ml, respectively. At 16.7G, the first-phase secretion peak (expressed as Cp value) was significantly lower with Ins200 (0.47 +/- 0.13 ng/ml, P < 0.02) and Ins400 (0.68 +/- 0.15 ng/ml, P < 0.05) than C (0.83 +/- 0.15 ng/ml). The second-phase secretion peak was also significantly (P < 0.05) reduced with added insulin (Ins200: 0.47 +/- 0.08 ng/ml; Ins400: 0.45 +/- 0.07 ng/ml) than in its absence (C: 0.65 +/- 0.09 ng/ml). Accordingly, total Cp secretion was lower with Ins200 (10.6 +/- 2.3 ng/ml, P = 0.03) and Ins400 (11.8 +/- 2.3 ng/ml) than with C (16.0 +/- 2.2 ng/ml).(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Targeting pancreatic β cells for diabetes treatment.

Jain C, Ansarullah , Bilekova S, Lickert H Nat Metab. 2022; 4(9):1097-1108.

PMID: 36131204 DOI: 10.1038/s42255-022-00618-5.


Improved in vivo imaging method for individual islets across the mouse pancreas reveals a heterogeneous insulin secretion response to glucose.

Frikke-Schmidt H, Arvan P, Seeley R, Cras-Meneur C Sci Rep. 2021; 11(1):603.

PMID: 33436691 PMC: 7804140. DOI: 10.1038/s41598-020-79727-8.


Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus.

Rachdaoui N Int J Mol Sci. 2020; 21(5).

PMID: 32150819 PMC: 7084909. DOI: 10.3390/ijms21051770.


Cyclic nucleotide phosphodiesterases in pancreatic islets.

Pyne N, Furman B Diabetologia. 2003; 46(9):1179-89.

PMID: 12904862 DOI: 10.1007/s00125-003-1176-7.


Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B.

Zhao A, Zhao H, Teague J, Fujimoto W, Beavo J Proc Natl Acad Sci U S A. 1997; 94(7):3223-8.

PMID: 9096374 PMC: 20350. DOI: 10.1073/pnas.94.7.3223.

References
1.
Tanaka R, Shima K, Sawazaki N, Matsuyama T, KUMAHARA Y, Yanaihara N . Failure of exogenous insulin to inhibit C-peptide release from the perfused rat pancreas. Endocrinol Jpn. 1980; 27(3):343-8. DOI: 10.1507/endocrj1954.27.343. View

2.
SODOYEZ J, FOA P . Evidence for an insulin-induced inhibition of insulin release by isolated islets of Langerhans. Proc Soc Exp Biol Med. 1969; 130(2):568-71. DOI: 10.3181/00379727-130-33608. View

3.
Patel Y, Amherdt M, Orci L . Quantitative electron microscopic autoradiography of insulin, glucagon, and somatostatin binding sites on islets. Science. 1982; 217(4565):1155-6. DOI: 10.1126/science.6126003. View

4.
GRODSKY G, FANSKA R, Schmid F . Evaluation of the role of exogenous insulin on phasic insulin secretion. Diabetes. 1973; 22(4):256-63. DOI: 10.2337/diab.22.4.256. View

5.
Verspohl E, Ammon H . Evidence for presence of insulin receptors in rat islets of Langerhans. J Clin Invest. 1980; 65(5):1230-7. PMC: 371457. DOI: 10.1172/JCI109778. View